patrice harris. she's also the emed co-founder and ceo.tor, thank you for being here first, so much of this new territory but could you venture to guess how long this process to scruitinize merck's emergency use authorization application for the pill might take? >> you know, it is difficult to say how long the fda will take to review, but as you note, it is fast-tracked, because this be a wonderful tool in the tool box, as we navigate our way through this phase of the pandemic, so as you know, it would receive emergency use authorization and so i believe that this is on the fast-track, but certainly, we'll have to take a look at the data and all the studies submitted, but again , we saw that the trial was ended early, because the results were so good, and so we have to let that process play out. liz: yeah, it hasn't exactly been peer reviewed yet and for people who don't know, this is very much, and we should be clear, this is not a prevention pill. this is a treatment pill, and as i understand it, obviously, you're the expert but this is